RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank75
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P75
Within normal range
Average
-1674.41%
Historical baseline
PeriodValueYoY Change
20240.00%-
20230.00%+100.0%
2022-5549.97%-210.2%
2021-1788.96%-73.2%
2020-1033.14%-